In silicodirected mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In silicodirected mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
Authors
Keywords
-
Journal
CELLULAR MICROBIOLOGY
Volume 14, Issue 12, Pages 1892-1903
Publisher
Wiley
Online
2012-08-17
DOI
10.1111/cmi.12008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathophysiological Mechanisms of Dominant and Recessive GLRA1 Mutations in Hyperekplexia
- (2013) S.-K. Chung et al. JOURNAL OF NEUROSCIENCE
- Hepatitis C Virus Induces CD81 and Claudin-1 Endocytosis
- (2012) Michelle J. Farquhar et al. JOURNAL OF VIROLOGY
- Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
- (2012) Bruno Sainz et al. NATURE MEDICINE
- Hepatitis C virus entry: beyond receptors
- (2012) Luke W. Meredith et al. REVIEWS IN MEDICAL VIROLOGY
- The cell biology of receptor-mediated virus entry
- (2011) Joe Grove et al. JOURNAL OF CELL BIOLOGY
- The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization
- (2011) H.-X. Wang et al. JOURNAL OF CELL SCIENCE
- A genetically humanized mouse model for hepatitis C virus infection
- (2011) Marcus Dorner et al. NATURE
- EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
- (2011) Joachim Lupberger et al. NATURE MEDICINE
- Molecular Modelling of the Emergence of Azole Resistance in Mycosphaerella graminicola
- (2011) Jonathan G. L. Mullins et al. PLoS One
- Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes
- (2010) Isabel Fofana et al. GASTROENTEROLOGY
- Claudin Association with CD81 Defines Hepatitis C Virus Entry
- (2010) Helen J. Harris et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Strategies for Targeting Tetraspanin Proteins
- (2009) Noha Hassuna et al. BIODRUGS
- Biophysical Properties of 9 KCNQ1 Mutations Associated With Long-QT Syndrome
- (2009) Tao Yang et al. Circulation-Arrhythmia and Electrophysiology
- Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations
- (2009) Sophie E. Krieger et al. HEPATOLOGY
- Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin
- (2009) G. P. Coffey et al. JOURNAL OF CELL SCIENCE
- Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
- (2009) M. E. Burlone et al. JOURNAL OF GENERAL VIROLOGY
- Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts
- (2009) L. Cukierman et al. JOURNAL OF VIROLOGY
- Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
- (2009) Alexander Ploss et al. NATURE
- Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo
- (2008) Philip Meuleman et al. HEPATOLOGY
- CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry
- (2008) H. J. Harris et al. JOURNAL OF VIROLOGY
- Clathrin- and Caveolin-Independent Entry of Human Papillomavirus Type 16—Involvement of Tetraspanin-Enriched Microdomains (TEMs)
- (2008) Gilles Spoden et al. PLoS One
- Hepatocyte Permissiveness to Plasmodium Infection Is Conveyed by a Short and Structurally Conserved Region of the CD81 Large Extracellular Domain
- (2008) Samir Yalaoui et al. PLoS Pathogens
- Formation of tight junction: determinants of homophilic interaction between classic claudins
- (2007) Jörg Piontek et al. FASEB JOURNAL
- Structural characterization of recombinant human CD81 produced in Pichia pastoris
- (2007) Mohammed Jamshad et al. PROTEIN EXPRESSION AND PURIFICATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started